J. Stathopoulos
Impact in
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 13
- Lung Cancer Research Studies 7
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 3
-
- Cancer therapeutics and mechanisms 6
- Co-authors
- George P. Stathopoulos (12 shared papers)J. Dimitroulis (9 shared papers)D. Antoniou (6 shared papers)S. Rigatos (7 shared papers)Athanasios Armakolas (2 shared papers)Dimitrios T. Trafalis (2 shared papers)Spyros Batzios (1 shared paper)G. Stathopoulos (4 shared papers)
In The Last Decade
J. Stathopoulos
18 papers receiving 441 citations
Peers
Comparison fields: 5 of 67
- Oncology 273
- Biomaterials 126
- Hepatology 50
- Pulmonary and Respiratory Medicine 98
- Cancer Research 42
Countries citing papers authored by J. Stathopoulos
This map shows the geographic impact of J. Stathopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Stathopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Stathopoulos more than expected).
Fields of papers citing papers by J. Stathopoulos
This network shows the impact of papers produced by J. Stathopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Stathopoulos. The network helps show where J. Stathopoulos may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Stathopoulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 96 | |
| 2 | 2010 | 90 | |
| 3 | 2011 | 83 | |
| 4 | 2003 | 39 | |
| 5 | Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects. | 2007 | 25 |
| 6 | 2005 | 20 | |
| 7 | 2005 | 18 | |
| 8 | 2004 | 13 | |
| 9 | 2005 | 12 | |
| 10 | Liposomal cisplatin dose escalation for determining the maximum tolerated dose and dose-limiting toxicity: a phase I study. | 2010 | 11 |
| 11 | Surgical management in lung metastases from colorectal cancer. | 2008 | 11 |
| 12 | 2006 | 10 | |
| 13 | 2010 | 9 | |
| 14 | 2012 | 7 | |
| 15 | 2006 | 5 | |
| 16 | 2012 | 3 | |
| 17 | 2007 | 1 | |
| 18 | 2010 | 1 |
About J. Stathopoulos
J. Stathopoulos is a scholar working on Oncology, Molecular Biology, Hepatology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 18 papers that have together received 454 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Research Studies (7 papers), Cancer therapeutics and mechanisms (6 papers), Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (3 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Oncology (273 citations), Biomaterials (126 citations), Hepatology (50 citations), Pulmonary and Respiratory Medicine (98 citations) and Cancer Research (42 citations). J. Stathopoulos has collaborated with scholars based in Greece and Belgium. Frequent co-authors include George P. Stathopoulos, J. Dimitroulis, D. Antoniou, S. Rigatos, Athanasios Armakolas, Dimitrios T. Trafalis, Spyros Batzios, G. Stathopoulos, Niki Georgatou and Dimitrios Veldekis. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer and Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.